Panel Discussion

Monday, March 9, 2026

11:10 AM - 11:30 AM EST

Location: Spotlight Theater

Moderator(s)

Lawrence Biegelsen, MBA

Managing Director Medical Supplies & Devices
Wells Fargo
Short Hills, New Jersey, United States

Disclosure(s): No financial relationships to disclose
Rick Wise, CFA

Research Analyst
Stifel
New York, New York, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Robert A. Byrne, MD, BCh, PhD

Director of Cardiology
Mater Private Hospital, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Dublin, Ireland

Disclosure(s): No financial relationships to disclose
Antonio Colombo, MD

Professor of Cardiology
Humanitas IRCCS
Milan, Lombardia, Italy

Disclosure(s): No financial relationships to disclose
Samuel Conaway, MBA

President Cardiology Sales
Boston Scientific Corporation
Miami, Florida, United States

Disclosure(s): Boston Scientific: Employee (Ongoing), Stock Options [in privately held companies] (Ongoing)
Jeffrey B. Jump, MSc

Chairman and CEO
MedAlliance
Nyon, Vaud, Switzerland

Disclosure(s): No financial relationships to disclose
Jeffrey W. Moses, MD, FSCAI

John and Myrna Daniels Professor of Cardiology
Columbia University Medical Center
New York, New York, United States

Disclosure(s): Abiomed (spouse): Consulting Fees (e.g., advisory boards) (Ongoing); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stock Options [in privately held companies] (Ongoing); Covanos: Stock Options [in privately held companies] (Ongoing); seimens: Consulting Fees (e.g., advisory boards) (Ongoing); Weightless Lead: Stock-privately held company (Ongoing)
Patrick W. Serruys, MD, PhD

Professor of Medical Intervention & Innovation
University of Galway, Ireland

Disclosure(s): Merillife Sciences: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Lawrence Biegelsen, MBA: No financial relationships to disclose

Rick Wise, CFA: No financial relationships to disclose

Robert A. Byrne, MD, BCh, PhD: No financial relationships to disclose

Antonio Colombo, MD: No financial relationships to disclose

Samuel Conaway, MBA: Boston Scientific: Employee (Ongoing), Stock Options [in privately held companies] (Ongoing)

Jeffrey B. Jump, MSc: No financial relationships to disclose

Jeffrey W. Moses, MD, FSCAI: Abiomed (spouse): Consulting Fees (e.g., advisory boards) (Ongoing); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stock Options [in privately held companies] (Ongoing); Covanos: Stock Options [in privately held companies] (Ongoing); seimens: Consulting Fees (e.g., advisory boards) (Ongoing); Weightless Lead: Stock-privately held company (Ongoing)

Patrick W. Serruys, MD, PhD: Merillife Sciences: Consulting Fees (e.g., advisory boards) (Ongoing)